VERSATILE
Live / Applied — Statement of use — non-final action mailed (as of 01 Sept 2026)
Now
Refused for now — an office action was mailed 01 Sept 2026.
A response is due by 01 Dec 2026; with no response the application is abandoned.
What this means for you
Not registered yet, but its 30 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97483940
- Mark type
- Word mark
- Filed
- 30 Jun 2022
- Published for opposition
- 18 Apr 2023
- Attorney of record
- Andrew T. Pettit
Goods and services
- Class 035 — Advertising and business services: Data processing services for medical, clinical, and scientific purposes; data processing services, namely, analysis of data related to primers to identify those primers that are able to induce a reaction of interest; data processing services, namely, analysis of data related to nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; data processing services for medical, clinical, and scientific purposes
- Class 042 — Scientific and technological services: Software as a service (SaaS), namely, hosting non-downloadable software for use by others for discovering combinations of primers for achieving a reaction of interest; software as a service (SaaS), namely, hosting non-downloadable software for use by others for simulating biological, chemical, and biochemical reactions through the use of artificial intelligence or machine learning; software as a service (SaaS), namely, hosting non-downloadable software for use by others for discovering tiling solutions for achieving a reaction of interest, each tiling solution being representative of a different combination of primers, and then determining the optimal tiling solution for achieving the reaction of interest; software as a service (SaaS), namely, hosting non-downloadable software for use by others for determining chemistry through the use of artificial intelligence or machine learning; software as a service (SaaS), namely, hosting non-downloadable software for use by others for designing primer pools for reactions without the need for laboratory testing; software as a service (SaaS), namely, hosting non-downloadable software for use by others for simulating interactions involving nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; software as a service (SaaS), namely, hosting non-downloadable software for use by others for bioinformatics; software as a service (SaaS), namely, hosting non-downloadable software for use by others for health and wellness assessment, namely, for use in genomic analysis; software as a service (SaaS), namely, hosting non-downloadable software for use by others for genetic and bioinformatics analysis; software as a service (SaaS), namely, hosting non-downloadable software for use by others for testing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules for research purposes; bioinformatics services, namely, product research and development in the field of bioinformatics; developing artificial intelligence algorithms and machine learning algorithms for medical, clinical, and scientific purposes; developing artificial intelligence algorithms and machine learning algorithms for use by others to develop products related to the diagnosis, management, or treatment of disease; consulting relating to research and development of products related to the diagnosis, management, or treatment of disease; providing a service for designing primers on behalf of others; providing a service for designing primers on behalf of healthcare entities, including hospital systems, pharmaceutical companies, and researchers
Owner
- Pillar Biosciences, Inc., Natick, MA, US
- Pillar Biosciences, Inc., Natick, MA, US
Prosecution history
- 01 Sept 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Sept 2026 — NON-FINAL ACTION E-MAILED
- 01 Sept 2026 — SU - NON-FINAL ACTION - WRITTEN
- 19 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Jun 2026 — USE AMENDMENT FILED
- 12 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
- 12 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 May 2026 — SOU EXTENSION 5 GRANTED
- 09 Dec 2025 — SOU EXTENSION 5 FILED
- 11 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 16 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2025 — SOU EXTENSION 4 GRANTED
- 15 May 2025 — SOU EXTENSION 4 FILED
- 15 May 2025 — SOU TEAS EXTENSION RECEIVED